Ragweed pollen allergen sublingual immunotherapy (Stallergenes)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRagweed pollen allergen sublingual immunotherapy (Stallergenes)
Drug Alias NameN/A
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesStallergenes Greer
China Registration ClassN/A

Develop Information

Active CompaniesStallergenes Greer
Inactive CompaniesN/A
Active IndicationsRhinitis, Allergic, Seasonal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A